/ Orphan drug biosimilar sponsors — Lysa
Who we serve

Orphan drug biosimilar sponsors

We are developing a universal scarless extraction method for protein drugs and filing against it. We want to talk to sponsors — and co-sponsor drugs.

In development Talk to us
FILINGTEMPLATEDRUG ADRUG BDRUG CSCARLESS EXTRACTIONSingle, proven processSAME FILE · ANY SCALE · ANY SITESCALE DOWNSCALE UPNEW SITE

One regulatory filing for the process, reused product after product, at whatever scale or site each one needs.

Why universal extraction matters

Today
The process decides who can afford a drug

A custom cell line and process cost as much to build for 400 patients as for 400,000. For rare indications that arithmetic kills validated medicine before regulation ever does.

With Lysa
Scarless extraction, one process for many drugs

Our method extracts a protein drug from a generic expression system without leaving scars, so the same process serves molecule after molecule, diminishing risk and sharing cost.

What we are looking for

✓
Sponsors Bring a molecule that deserves a process it can afford. We develop and file together.
✓
Co-sponsors Share cost and risk of establishing the production route on your molecule class.
✓
In development No pharmaceutical applications yet.

Bring us a drug that needs a cheaper process

Tell us the molecule, the indication and the patient population you serve.

Open a conversation